Your browser doesn't support javascript.
loading
Multicentre propensity-matched comparison of transcatheter aortic valve implantation using the ACURATE TA/neo self-expanding versus the SAPIEN 3 balloon-expandable prosthesis.
Barth, Sebastian; Reents, Wilko; Zacher, Michael; Kerber, Sebastian; Diegeler, Anno; Schieffer, Bernhard; Schreiber, Matthias; Lauer, Bernward; Kuntze, Thomas; Dahmer, Marko; Hamm, Christian; Hamm, Karsten.
Afiliación
  • Barth S; Department of Cardiology, Cardiovascular Center Bad Neustadt, Bad Neustadt a. d. Saale, Germany.
EuroIntervention ; 15(10): 884-891, 2019 Nov 20.
Article en En | MEDLINE | ID: mdl-31270034
AIMS: In the absence of randomised data, we aimed to compare the transapical ACURATE and transfemoral ACURATE neo with the SAPIEN 3 prosthesis using propensity matching. METHODS AND RESULTS: From 2012 to 2016, 1,306 patients at three German centres received either the ACURATE/ACURATE neo prosthesis (n=591) or the SAPIEN 3 prosthesis (n=715). Through nearest neighbour matching with exact allocation for access route and centre, pairs of 329 patients (250 transfemoral, 79 transapical) per group were determined. Patients were 81 years old on average and had a logistic EuroSCORE I of 19%. Predilatation and post-dilatation were more frequent in the ACURATE group (97.6% versus 52.1%, p<0.001 for predilatation and 40.4% versus 11.6%, p<0.001 for post-dilatation), but rapid pacing for implantation was used less frequently (37.1% versus 98.2%, p<0.001). More-than-mild aortic regurgitation at postoperative echocardiography was 12.0% for the ACURATE group and 3.1% for the SAPIEN group, p≤0.001). More-than-mild aortic regurgitation in the ACURATE group differed amongst the centres with 6.0% (3/50) in centre A, 34.1% (29/85) in centre B and 3.4% (6/181) in centre C. Patients in the ACURATE group less frequently had pacemaker implantation compared to the SAPIEN 3 group (11.9% versus 18.5%, p=0.020), 30-day mortality was 4.6% versus 2.1%, respectively, p=0.134, and one-year survival was 83.1% (95% CI: 77.6-87.4) versus 88.8% (95% CI: 84.0-92.2). CONCLUSIONS: In this propensity score analysis, patients treated with the transapical ACURATE or transfemoral ACURATE neo prosthesis less frequently had pacemakers at 30 days but had more aortic regurgitation and lower one-year survival.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Insuficiencia de la Válvula Aórtica / Estenosis de la Válvula Aórtica / Prótesis Valvulares Cardíacas / Implantación de Prótesis de Válvulas Cardíacas / Reemplazo de la Válvula Aórtica Transcatéter Tipo de estudio: Clinical_trials Idioma: En Revista: EuroIntervention Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Insuficiencia de la Válvula Aórtica / Estenosis de la Válvula Aórtica / Prótesis Valvulares Cardíacas / Implantación de Prótesis de Válvulas Cardíacas / Reemplazo de la Válvula Aórtica Transcatéter Tipo de estudio: Clinical_trials Idioma: En Revista: EuroIntervention Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Año: 2019 Tipo del documento: Article